Edition:
United Kingdom

Rosetta Genomics Ltd (ROSG.OQ)

ROSG.OQ on NASDAQ Stock Exchange Capital Market

0.35USD
9:00pm BST
Change (% chg)

$-0.02 (-5.43%)
Prev Close
$0.37
Open
$0.38
Day's High
$0.38
Day's Low
$0.34
Volume
4,251
Avg. Vol
36,315
52-wk High
$2.82
52-wk Low
$0.26

Chart for

About

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests-based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next... (more)
No analyst recommendations are available for .

Overall

Beta: 0.49
Market Cap(Mil.): $2.22
Shares Outstanding(Mil.): 5.93
Dividend: --
Yield (%): --

Financials

  ROSG.OQ Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -6.20 -- --
ROI: -144.23 -0.74 13.19
ROE: -170.31 -2.80 15.00

BRIEF-Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics

* SABBY MANAGEMENT LLC REPORTS PURCHASE OF 105,361 ADR SHARES OF ROSETTA GENOMICS LTD BETWEEN MARCH 14 AND 15 -SEC FILING Source text: (http://bit.ly/2pkA5FR) Further company coverage:

16 Mar 2018

BRIEF-Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics

* GENOPTIX ANNOUNCES TERMINATION OF MERGER AGREEMENT WITH ROSETTA GENOMICS AND NOW FOCUSED ON NEXT STEPS

26 Feb 2018

Earnings vs. Estimates